Brief: Synact Pharma Appoints Malin Wikstrand As Interim CFO
Jan 19 (Reuters) - SynAct Pharma AB SYNACT.ST: APPOINTS MALIN WIKSTRAND AS INTERIM CFO ROLE EFFECTIVE AS OF JANUARY 19, 2026 Source text: ID:nMFNyMQWj Further company coverage: SYNACT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on SynAct Pharma AB
See all newsSweden's SynAct Pharma Q3 net loss narrows as expenses fall
Brief: SynAct Pharma Q3 Net Income SEK -32.177 Million
Brief: SynAct Pharma Signs First Commercial Partnership For Resomelagon
Brief: WHO Names Resomelagon Among Key Dengue Drug Candidates
Brief: SynAct Pharma Says Advance Analysis Supports Phase 3 Development